Top Stock Losers
Explore the biggest stock losers today along with up-to-date performance data, including the latest price, share price changes, trading volume, and more. We cover the top stock losers and decliners every day with market data, news, and analysis from our Foolish experts.
Related Articles
Featured Article
Rocket Pharmaceuticals Stock Is Blasting Off, but Here's Why You Should Tread Carefully
Alex Carchidi
|
Sep 18, 2023
Its near-term risks are subtle but bigger than their flying stock price might indicate.
Why Shares of Rocket Pharmaceuticals Are Taking Off on Wednesday
Jim Halley
|
Sep 13, 2023
The late-stage pharmaceutical company said it had reached an agreement with the Food and Drug Administration regarding a phase 2 trial for a Danon disease therapy.
NeuroPace, Inc. (NPCE) Q2 2022 Earnings Call Transcript
Motley Fool Transcribing
|
Aug 12, 2022
NPCE earnings call for the period ending June 30, 2022.
NeuroPace, Inc. (NPCE) Q1 2022 Earnings Call Transcript
Motley Fool Transcribing
|
May 13, 2022
NPCE earnings call for the period ending March 31, 2022.
NeuroPace, Inc. (NPCE) Q4 2021 Earnings Call Transcript
Motley Fool Transcribing
|
Mar 10, 2022
NPCE earnings call for the period ending December 31, 2021.
NeuroPace, Inc. (NPCE) Q3 2021 Earnings Call Transcript
Motley Fool Transcribing
|
Nov 11, 2021
NPCE earnings call for the period ending September 30, 2021.
With Prothena Up Over 500% This Year, Is It Too Late to Get in?
Jeff Little
|
Sep 18, 2021
Promising drug candidates could lead to a best-in-class Alzheimer's treatment.
NeuroPace, Inc. (NPCE) Q2 2021 Earnings Call Transcript
Motley Fool Transcribing
|
Aug 13, 2021
NPCE earnings call for the period ending June 30, 2021.
Could This Recently IPOed Medical Device Maker Make You Rich?
Patrick Bafuma
|
Jul 3, 2021
Small-cap epilepsy treatment specialist NeuroPace looks a lot like Abiomed did in its early days.
Prothena (PRTA) Q4 2019 Earnings Call Transcript
Motley Fool Transcribing
|
Feb 12, 2020
PRTA earnings call for the period ending December 31, 2019.
View More Articles